Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MBX compared with ZBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
MBX
MBX Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
ZBIO
Zenas BioPharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MBX
MBX Biosciences, Inc.
vs
ZBIO
Zenas BioPharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
MBX
with
ZBIO
Uncorrelated: r 0.23 · 499D.
Shared co-movers
3
with MBX
with ZBIO
SYRE
Spyre Therapeutics, Inc.
r 0.30
r 0.36
ORKA
Oruka Therapeutics, Inc.
r 0.27
r 0.35
IMVT
Immunovant, Inc.
r 0.26
r 0.36
MBX, solid
ZBIO, hatched
r = correlation
Bar = r to r 0.75
Order: weaker of A and B
Source: daily closes
MBX
MBX Biosciences, Inc.
Change
48.43
· pre 48.43
· delayed
Mkt cap
$2.3B
Revenue
—
ZBIO
Zenas BioPharma, Inc.
Change
26.08
· pre 25.00
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$1.7B
Revenue
$10M
Q3 FY26
vs
Compare
Pre-market
Nov 5 '26
delayed
MBX
MBX Biosciences, Inc.
vs
ZBIO
Zenas BioPharma, Inc.
48.43
pre 48.43
delayed
Price
26.08
pre 25.00
delayed
$2.3B
Mkt cap
$1.7B
—
Revenue
$10M
Q3 FY26
Change
Change
MBX
48.43
vs
ZBIO
26.08
Pre-market
Nov 5 '26
delayed